Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-25 to 2023-09-15
Current total value of award: $267.62
Description: 8510105252!HEPATITIS B VIRUS V